Information Provided By:
Fly News Breaks for December 9, 2019
Dec 9, 2019 | 11:00 EDT
Evercore ISI analyst Joshua Schimmer downgraded Synthorx (THOR) to In Line from Outperform after the company agreed to be acquired Sanofi (SNY) for $68 per share in cash.
News For THOR From the Last 2 Days
There are no results for your query THOR